Resistance to nondepolarizing neuromuscular blocking agents

Pharmacotherapy

Volumn 16, Issue 3 I, 1996, Pages 409-418

  Tschida, Suzanne J ^b   Graupe, Kimberly J ^b   Hoey, Lori L ^b   Vance Bryan, Kyle ^a  

^a REGIONS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ATRACURIUM; BETAMETHASONE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR; DIMETHYLTUBOCURARINE CHLORIDE; DOXACURIUM; HYDROCORTISONE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PREDNISONE; TESTOSTERONE; THEOPHYLLINE; TUBOCURARINE CHLORIDE; VECURONIUM;

ANTICONVULSANT THERAPY; BURN; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG TOLERANCE; HUMAN; IMMOBILIZATION; INTRAVENOUS DRUG ADMINISTRATION; NEUROMUSCULAR BLOCKING; PHARMACOECONOMICS; RECEPTOR UPREGULATION; REVIEW;

ANIMALS; DRUG RESISTANCE; HUMANS; MUSCLE, SKELETAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RECEPTORS, CHOLINERGIC; TACHYPHYLAXIS;

EID: 0029897493     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Yate PM, Flynn PJ, Arnold RW, Weatherly EC, Simmonds RJ, Dopson T. Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Er J Anaesth 1987;59:211-17.
2. Coursin DB, Klasek G, Goelzer SL. Increased requirements for continuously infused vecuronium in critically ill patients. Anesth Analg 1989;69:518-21.
3. Dwersteg JF, Pavlin EG, Heimbach DM. Patients with bums are resistant to atracurium. Anesthesiology 1986;65:517-20
4. Ornstein E, Matteo RS, Silverberg PA, Schwartz AE, Young WL. Dose-response relationship for vecuronium in the presence of chronic phenytoin therapy [abstr]. Anesth Analg 1986;65:S116.
5. Ornstein E, Matteo RS, Silverberg PA, Schwartz AE, Young WL. Chronic phenytoin therapy and nondepolarizing muscular blockade [abstr]. Anesthesiology 1985;63:A331.
6. Ornstein E, Matteo RS, Young WL, Diaz J. Resistance to metocurine induced neuromuscular blockade in patients receiving phenytoin. Anesthesiology 1985;63:294-8.
7. Ornstein E, Matteo RS, Schwanz AE, Silverberg PA, Young WL, Diaz J. The effect on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology 1987;67:191-6.
8. Ornstein E, Matteo RS, Weinstein JA, Halevy JD, Young WL, Abou-Donia MM. Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy. J Clin Anesth 1991;3:108-11.
9. Kim CS, Arnold FJ, Itani MS, Martyn JAJ. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology 1992;77:500-6.
10. Chen J, Kim YD, Dubois M, Kammerer W, Macnamara TE. The increased requirement of pancuronium in neurosurgical patients receiving Dilantin chronically [abstr]. Anesthesiology 1983;59:A288.
11. Modica P, Tempelhoff R. Effect of chronic anticonvulsant therapy on recovery from atracurium [abstr]. Anesth Analg 1989;68:S198.
12. Platt PR, Thackray NM. Phenytoin-induced resistance to vecuronium. Anaesth Intensive Care 1993;21:185-91.
13. Tempelhoff R, Modica PA, Jellish WS, Spitznagel EL. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg 1990;71:665-9.
14. Roth S, Ebrahim ZY. Resistance to pancuronium in patients receiving carbamazepine. Anesthesiology 1987;66:691-3.
15. Whalley DG, Ebrahim Z. Influence of carbamazepine on the dose-response relationship of vecuronium. Br J Anaesth 1994;72:125-6.
16. Kim CS, Arnold FJ, Itani MS, Martyn JAJ. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology 1992;77:500-6.
17. Mickey DR, Sangwan S, Bevan JC. Phenytoin-induced resistance to pancuronium:use of atracurium infusion in management of a neurosurgical patient. Anaesthesia 1988;43:757-9.
18. Kumar CM, Lawler PGP. Phenytoin-induced resistance to vecuronium. Anaesthesia 1989;44:263-4.
19. Norman J. Resistance to vecuronium. Anaesthesia 1993;48:1068-9.
20. Laflin MJ. Interaction of pancuronium and corticosteroids. Anesthesiology 1977;47:471-2.
21. Robinson BJ, Lee E, Rees D, Purdie GL, Galletly DC. Betamethasone-induced resistance to neuromuscular blockade:a comparison of atracurium and vecuronium in vitro. Anesth Analg 1992;74:762-5.
22. Parr SM, Galletly DC, Robinson BJ. Betamethasone-induced resistance to vecuronium:a potential problem in neurosurgery? Anaesth Intensive Care 1991;19:103-5.
23. Reddy P, Guzman A, Robalino J, Shevde K. Resistance to muscle relaxants in a patient receiving prolonged testosterone therapy. Anesthesiology 1989;70:871-3.
24. Meyers EF. Partial recovery from pancuronium neuromuscular blockade following hydrocortisone administration. Anesthesioiogy 1977;46:148-50.
25. Mishra Y, Ramzan I. Ranitidine reverses gallamine paralysis in rats. Anesih Analg 1993;76:627-30.
26. Law SC, Ramzan IM, Brandom BW, Cook DR. Intravenous ranitidine antagonizes intense atracurium-induced neuromuscular blockade in rats. Anesth Analg 1989;69:611-13.
27. Katende RS, Dimich I. Resistance to nondepolarizing muscle relaxants in a patient treated with ranitidine. Mt Sinai J Med 1987;54:330-1.
28. Doll DC, Rosenberg H. Antagonism of neuromuscular blockade by theophylline. Anesth Analg 1979;58:139-40.
29. Daller JA, Erstad B, Rosado L, Otto C, Putnam CW. Aminophylline antagonizes the neuromuscular blockade of pancuronium but not vecuronium. Crit Care Med 1991:19:983-5.
30. Azar I, Kumar D, Betcher AM. Resistance to pancuronium in an asthmatic patient treated with aminophylline and steroids. Can Anaesth Soc J 1982;29:280-2.
31. Gronert GA, Matteo RS, Perkins S. Canine gastrocnemius disuse atrophy:resistance to paralysis by dimethyl tubocurarine. J Appl Physiol 1984;57:1502-6.
32. Gronert GA. Disuse atrophy with resistance to pancuronium. Anesthesiology 1981;55:547-9.
33. Matteo RS, Diaz J. Resistance to d-tubocurarine in cats following 72 hours of continuous paralysis [abstr]. Anesthesiology 1984;61:A310.
34. Fung D, Perkins S. Disuse resistance to metocurine [abstr]. Anesthesiology 1989;71:A786.
35. Brett RS, Schmidt JH, Gage JS, Schartel SA, Poppers PJ. Measurement of acetylcholine receptor concentration in skeletal muscle from a patient with multiple sclerosis and resistance to atracurium. Anesthesiology 1987;66:837-9.
36. Moorthy SS, Krishna G, Dierdorf SF. Resistance to vecuronium in patients with cerebral palsy. Anesth Analg 1991;73:275-7.
37. Moorthy SS, Hilgenberg JC. Resistance to nondepolarizing muscle relaxants in paretic upper extremities of patients with residual hemiplegia. Anesth Analg 1980;59:624-7.
38. Shayevitz JR, Matteo RS. Decreased sensitivity to metocurine in patients with upper motoneuron disease. Anesth Analg 1985;64:767-72.
39. Laycock JRD, Smith CE, Donati F, Bevan DR. Sensitivity of the adductor pollicis and diaphragm muscles to atracurium in a hemiplegic patient. Anesthesiology 1987;67:851-3.
40. Dretchen KL, Morgenroth VH, Standaert FG, Walts LF. Effects on neuromuscular transmission. Anesthesiology 1976;45:604-9.
41. Marathe PH, Dwersteg JF, Pavlin EG, Haschke RH, Heimbach DM, Slattery JT. Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humans. Anesthesiology 1980;70:752-5.
42. Pavlin EG, Haschke RH, Marathe P, Slattery JT, Howard ML, Butler SH. Resistance to atracurium in thermally injured rats. Anesthesiology 1988;69:696-701.
43. Lagasse RS, Gage JS, Schartel SA. Acetylcholine receptors and resistance to atracurium in humans with thermal injury (abstr). Anesth Analg 1990;70:S222.
44. Mills AK, Martyn JAJ. Neuromuscular blockade with vecuronium in paediatric patients with burn injury. Br J Clin Pharmacol 1989;28:155-9.
45. Martyn JAJ, Szyfelbein SK, AH HH, Matteo RS, Savarese JJ. Increased d-tubocurarine requirement following major thermal injury. Anesthesiology 1980;52:352-5.
46. Martyn JAJ, Goudsouzian NG, Matteo RS, Liu LMP, Szyfelbein SK, Kaplan RF. Metocurine requirements and plasma concentrations in burned paediatric patients. Br J Anaesth 1983;55:263-8.
47. Martyn JAJ, Liu LMP, Szyfelbein SK, Ambalavanar ES, Goudsouzian NG. The neuromuscular effects of pancuronium in burned children. Anesthesiology 1983;59:561-4.
48. Martyn JAJ, Matteo RS, Szyfelbein SK, Kaplan RF. Unprecedented resistance to neuromuscular blocking effects of metocurine with persistence after complete recovery in a burned patient. Anesth Analg 1982;61:614-16.
49. Yamashita M, Shiga T, Matsuki A, Oyama T. Unusual resistance to pancuronium in severely burned patients:case reports. Can Anaesth Soc J 1982;29:630-1.
50. Dwersteg JF, Pavlin EG, Heimbach DM. Patients with burns are resistant to atracurium. Anesthesiology 1986;65:517-20.
51. Hogue CW, Ward JM, Itani MS, Martyn JAJ. Tolerance and upregulation of acetylcholine receptors follow chronic infusion of d-tubocurarine. J Appl Physiol 1992;72:1326-31.
52. Hogue CW, Itani MS, Martyn JAJ. Resistance to d-tubocurarine in lower motor neuron injury is related to increased acetylcholine receptors at the neuromuscular junction. Anesthesiology 1990;73:703-9.
53. Fiacchino F, Gemma M, Bricchi M, Giudici D, Ciano C. Hypo- and hypersensitivity to vecuronium in a patient with Guillain-Barrésyndrome. Anesth Analg 1994;78:187-9.
54. Gyasi HK, Naguib M. Atracurium and severe hepatic disease:a case report. Can Anaesth Soc J 1985;32:161-4.
55. Dundee JW, Gray CT. Resistance to d-tubocurarine chloride in the presence of liver damage. Lancet 1953;2:16-17.
56. Tatman AJ, Wrigley SR, Jones RM. Resistance to atracurium in a patient with an increase in plasma alphai globulins. Br J Anaesth 1991;67:623-5.
57. Ip Yam CI, Wood P. Repeated resistance to non-depolarizing neuromuscular blocking drugs in a patient with multiple myeloma [letter]. Br J Anaesth 1992;69:111.
58. Callanan DL. Development of resistance to pancuronium in adult respiratory distress syndrome. Anesth Analg 1985;64:1126-8.
59. Branney SW, Haenel JB, Moore FA, Tarbox BB, Schreiber RH, Moore EE. Prolonged paralysis with atracurium infusion:a case report. Crit Care Med 1994;22:1699-1701.
60. Kelly KJ, Clarens DM, Kohls PR, Nahum A, Vance-Bryan K. Response to pancuronium after loss of atracurium-induced neuromuscular blockade. Ann Pharmacother 1993;27:862-5.
61. Coursin DB, Meyer DA, Prielipp RC. Doxacurium infusion in critically ill patients with atracurium tachyphylaxis. Am J Health Syst Pharm 1995;52:635-9.
62. Tschida SJ, Hoey LL, Nahum A, Vance-Bryan K. Atracurium resistance in a critically ill patient. Pharmacotherapy 1995;15(4):533-9.
63. Martyn JAJ, White DA, Gronert GA, Jaffe RS, Ward JM. Upand down-regulation of skeletal muscle acetylcholine receptors. Anesthesiology 1992;76:822-43.
64. Gwee MCE, Cheah LS, Shoon ML. Cimetidine and ranitidine:a study of competitive and ion-channel blockade in the toad isolated reclus abdominis muscle. Clin Exp Pharmacol Physiol 1986;13:613-18.
65. Cheah LS, Lee HS, Gwee MCE. Anticholinesterase activity of and possible ion-channel block by cimetidine, ranitidine and oxmetidine in the toad isolated reclus abdominis muscle. Clin Exp Pharmacol Physiol 1985;12:353-7.
66. Vandenbroom RHG, Wierda MKH, Agoston S. Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function. Clin Pharmacokinet 1990;19:230-40.
67. Nigrovic V, Smith S. Involvement of nucleophiles in the inactivation of atracurium. Br J Anaesth 1987;59:617-21.
68. Nigrovic V, Fox JL. Atracurium decay and the formation of laudanosine in humans. Anesthesiology 1991;74:446-54.
69. Duvaldestin P, Agoston S, Henzel D, Kersten UW, Desmonts JM. Pancuronium pharmacokinetics in patients with liver cirrhosis. Br J Anaesth 1978;50:1131-6.
70. Duvaldestin P, Henzel D. Binding of tubocurarine, fazadinium, pancuronium and ORG NC 45 to serum proteins in normal man and in patients with cirrhosis. Br J Anaesth 1982;54:513-16.
71. Leibel WS, Martyn JAJ, Szyfelbein SK, Miller KW. Elevated plasma binding cannot account for the burn-related d-tubocurarine hyposensitivity. Anesthesiology 1981;54:378-82.
72. Hughes R, Chapple DJ. The pharmacology of atracurium a new competitive neuromuscular blocking agent. Br J Anaesth 1981;53:31-43.
73. Merrett RA, Thompson CW, Webb FW. In vitro degradation of atracurium in human plasma. Br J Anaesth 1983;55:61-6.
74. McEvoy GK, Litvak K, Welsh OH, eds. AHFS 96 drug information Bethesda, MD:American Society of Hospital Pharmacists, 1996:933-947.
75. Brockes JP, Hall ZW. Acetylcholine receptors in normal and denervated rat diaphragm muscle. II. Comparison of junctional and extrajunctional receptors. Biochemistry 1975;14:2100-6.
76. Lapa AJ, Albuquereque EX, Daly J. An electrophysiological study of the effects of d-tubocurarine, atropine and alpha-bungarotoxin on cholinergic receptor on innervated and chronically denervated mammalian skeletal muscles. Exp Neurol 1974;43:375-98.
77. Beranek R, Vyskocil F. The action of tubocurarine and atropine on normal and denervated rat skeletal muscle. J Physiol 1967;188:53-66.
78. Gu Y, Hall ZW. Immunological evidence for a change in subunits of acetylcholine receptor in developing and denervated rat muscle. Neuron 1988;1:117-25.
79. Kirn C, Fuke N, Martyn JAJ. Burn injury to rat increases nicotinic acetylcholine receptors in the diaphragm. Anesthesiology 1988;68:401-6.
80. Iwasaki H, Namiki A, Omote K, Omote T, Takahashi T. Response differences of paretic and healthy extremities to pancuronium and neostigmine in hemiplegic patients. Aneslh Analg 1985:64:864-6.
81. Kirn C, Martyn J, Nobuo F. Burn injury to trunk of rat causes denervation-like response in the gastrocnemius muscle. J Appl Physiol 1988;65:1745-51.
82. Kim CS, Arnold FJ, Itani MS, Martyn JAJ. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology 1992;77:500-6.
83. Graham DH. Monitoring neuromuscular block may be unreliable in patients with upper-motor-neuron lesions. Anesthesiology 1980;52:74-5.
84. Matsuki A. Unusual resistance to muscle relaxant in a burnt patient. Anaesth Intensive Care 1979;7:287-8.
85. Mills AK, Martyn JAJ. Evaluation of atracurium neuromuscular blockade in paediatric patients with burn injury. Br J Anaesth 1988;60:450-5.
86. Martyn J. Clinical pharmacology and drug therapy in the burned patient. Anesthesiology 1986;65:67-75.
87. Martyn J, Goldhill DR, Goudsouzian NG. Clinical pharmacology of muscle relaxants in patients with burns. J Clin Pharmacol 1986;26:680-5.
88. Kelly SS, Morgan GP, Smith JW. The origin of (+) tubocurarine resistance in dystrophic mice. Br J Pharmacol 1986;89:47-53.
89. Storella RJ, Martyn JAJ, Bierkamper GG. Anti-curare effect of plasma from patients with thermal injury. Life Sci 1988;43:35-40.
90. Tomera JF, Martyn JAJ. Increases in burn size and resulting changes at the neuromuscular junction in mice [abstr]. Physiologist 1986;29:156.
91. Viby-Mogensen J, Hanel HK, Hansen E, Sorensen B, Graae J. Serum cholinesterase activity in burned patients. I. Biochemical findings. Acta Anaesthesiol Scand 1975;19:159-68.
92. Chapple DJ, Dodd P, Maclead DM, Withington PS, Yate PM. Requirements for neuromuscular blocking agents during prolonged anaesthesia in the anaesthetized dog [letter]. Br J Anaesth 1987;59:1321P-2.
93. Waud BE, Waud DR. Tubocurarine sensitivity of the diaphragm after limb immobilization. Anesth Analg 1986;65:493-5.
94. Waud BE, Amaki Y, Waud DR. Disuse and d-tubocurarine sensitivity in isolated muscles. Anesth Analg 1985;64:1178-82.
95. Fahim MA. Rapid neuromuscular remodeling following limb immobilization. Anat Rec 1989;224:102-9.
96. Duchateau J, Hainaut K. Electrical and mechanical changes in immobilized human muscle. J Appl Physiol 1987;62:2168-73.
97. Chang CC, Chuang S, Huang MC. Effects of chronic treatment with various neuromuscular blocking agents on the number and distribution of acetylcholine receptors in the rat diaphragm. J Physiol 1975;250:161-73.
98. Berg DK, Hall ZW. Increased extrajunctional acetylcholine sensitivity produced by chronic post-synaptic neuromuscular blockade. J Physiol 1975;244:659-76.
99. Gray HSJ, Slater RM, Pollard BJ. The effect of acutely administered phenytoin on vecuronium-induced neuro-muscular blockade. Anaesthesia 1989;44:379-81.
100. AIloul K, Varin F. Carbamazepine induced changes on vecuronium pharmacokinetics in anesthetized patients [abstr]. Clin Pharmacol Ther 1994;55:P179.
101. Alderice MT, Trommer BA. Differential effects of the anticonvulsants phenobarbital, ethosuximide, and carbamazepine on neuromuscular transmission. J Pharmacol Exp Ther 1980;215:92-6.
102. Nigrovic V, Banoub M. Pharmacokinetic modelling of a parent drug and its metabolite. Clin Pharmacokinet 1992;22:396-408.
103. 2-antagonists. Z Gastroenterol 1984:22:109-12.
104. Katende RS, Dimich I. Resistance to nondepolarizing muscle relaxants in a patient treated with ranitidine. Mt Sinai J Med 1987:54:330-1.
105. 2-receptor antagonist pretreatment on vecuronium- and atracurium-induced neuromuscular block. Br J Anaesth 1991:66:713-15.
106. Parker CJR, Hunter JM. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis. Br J Anaesth 1989;62:177-83.
107. Duvaldestin P, Saada J, Henzel D, Saumon G. Fazadinium pharmacokinetics in patients with liver disease. Br J Anaesth 1980;52:789-91.
108. Ramzan MI, Somogyi AA, Walker JS, Shankds CA, Triggs EJ. Clinical pharmacokinetics of the non-depolarizing muscle relaxants. Clin Pharmacokinet 1981;6:25-60.
109. Arden JR, Lynam DP, Castagnoli KP, Canfell PC, Cannon JC, Miller RD. Vecuronium in alcoholic liver disease;a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 1988;68:771-6.
110. Wood M. Plasma drug binding:implications for anesthesiologists. Anesth Analg 1986;65:786-804.
111. Wood M, Stone WJ, Wood AJJ. Plasma binding of pancuronium:effects of age, sex, and disease. Anesth Analg 1983;62:29-32.
112. Hunter JM. Resistance to non-depolarizing neuromuscular blocking agents. Br J Anaesth 1991;67:511-14.
113. Stovner J, Theodorsen L, Bjelke E. Sensitivity to tubocurarine and alcuronium with special reference to plasma protein pattern. Br J Anaesth 1971;43:385-91.
114. Baraka A, Gabali F. Correlation between tubocurarine requirements and plasma protein pattern. Br J Anaesth 1968;40:89-93.
115. Bell CF, Hunter JM, Jones RS, Utting JE. Use of atracurium and vecuronium in patients with oesophageal varices. Br J Anaesth 1985;57:160-8.
116. Ward ME, Adu-Gyamfi Y, Strunin L. Althesin and pancuronium in chronic liver disease. Br J Anaesth 1975:47:1199-1201.
117. Ghoneim MM, Kramer E, Bannow R, Pandya H, Routh JI. Binding of d-tubocurarine to plasma proteins in normal man and in patients with hepatic or renal disease. Anesthesiology 1973:39:410-12.
118. Ono K, Nagano O, Ohta Y, Kosaka F. Neuromuscular effects of respiratory and metabolic acid-base changes in vitro with and without nondepolarizing muscle relaxants. Anesthesiology 1990;73:710-16.
119. Aziz L, Ono K, Ohta Y, Morita K, Hirakawa M. The effect of COi-induced acid-base changes on the potencies of muscle relaxants and antagonism of neuromuscular block by neostigmine in rat in vitro. Anesth Analg 1994;78:322-7.
120. Gencarelli PJ, Swen J, Koot HWJ, Miller RD. The effects of hypercarbia and hypocarbia on pancuronium and vecuronium neuromuscular blockades in anesthetized humans. Anesthesiology 1983;59:376-80.
121. Miller RD, Roderick LL. Acid-base balance and neostigmine antagonism of pancuronium neuromuscular blockade. Br J Anaesth 1978;50:317-23.
122. Fisher DM, Canfell PC, Fahey MR, et al. Elimination of atracurium in humans:contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 1986;65:6
123. Neill EAM, Chappie DJ, Thompson CW. Metabolism and kinetics of atracurium:an overview. Br J Anaesth 1983;55:23S-5.
124. Flynn PJ, Hughes R, Walton B, Jothilingam S. Use of atracurium infusions for general surgical procedures including cardiac surgery with induced hypothermia. Br J Anaesth 1983;55:135S-8.
125. Denny NM, Kneeshaw JD. Vecuronium and atracurium infusions during hypothermie cardiopulmonary bypass. Anesthesia 1986:41:919-22.
126. Thornton RJ, Blakeney C, Feldman SA. The effect of hypothermia on neuromuscular conduction. Br J Anaesth 1976;48:264-74.